Chlamydia is the most prevalent bacterial sexually transmitted infection (STI) in the world. There is no vaccine to prevent infection. However, researchers from the University of North Carolina at Chapel Hill, in partnership with colleagues at other sites in the US, Europe and Australia, will receive up to $10.7 million over five years from the National Institutes of Health (NIH) to move closer to identifying a vaccine candidate.
Source: News Medical, https://www.news-medical.net/